Patents by Inventor Amy McPherson

Amy McPherson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9428792
    Abstract: The present disclosure relates to nucleic-acid based product authentication and identification by determining authentication codes comprising target nucleic acids using oligonucleotide probes associated with samples. The presence of the authentication code is determined using detection methods, such as flow cytometric methods, capable of particle discrimination based on the light scattering or fluorescence properties of the particle. Target-correlated fluorescence signal, originating from a target nucleic acid hybridized to labeled complementary oligonucleotides is determined as an indicator of the presence of the authentication code. In some embodiments, an intercalating dye is used to determine the presence of target nucleotide/oligonucleotide heterodimers and identify an authentication code.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 30, 2016
    Assignee: CertiRx Corporation
    Inventors: Thomas J. Mercolino, Amy McPherson, James Garber Rudulph, Jr.
  • Publication number: 20140272973
    Abstract: The present disclosure relates to nucleic-acid based product authentication and identification by determining authentication codes comprising target nucleic acids using oligonucleotide probes associated with samples. The presence of the authentication code is determined using detection methods, such as flow cytometric methods, capable of particle discrimination based on the light scattering or fluorescence properties of the particle. Target-correlated fluorescence signal, originating from a target nucleic acid hybridized to labeled complementary oligonucleotides is determined as an indicator of the presence of the authentication code. In some embodiments, an intercalating dye is used to determine the presence of target nucleotide/oligonucleotide heterodimers and identify an authentication code.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: CertiRx Corporation
    Inventors: Thomas J. Mercolino, Amy McPherson, James Garber Rudulph, JR.